Mascoma Wealth Management’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.77K Sell
8
-1
-11% -$277 ﹤0.01% 465
2026
Q1
$2.66K Buy
9
+3
+50% +$891 ﹤0.01% 404
2025
Q4
$1.64K Buy
+6
New +$1.63K ﹤0.01% 425
2025
Q1
Sell
-425
Closed -$98.7K 505
2024
Q4
$98.7K Sell
425
-25
-6% -$5.75K 0.02% 141
2024
Q3
$99.3K Sell
450
-10
-2% -$2.07K 0.02% 140
2024
Q2
$90.4K Buy
+460
New +$95K 0.02% 147
2022
Q2
Sell
-4
Closed -$1K 607
2022
Q1
$1K Hold
4
﹤0.01% 566
2021
Q4
$1K Buy
+4
New +$880 ﹤0.01% 511

Other funds holding CME

Mascoma Wealth Management's CME Position: Q2 2026 in Review

Mascoma Wealth Management reduced its CME Group (CME) stake by 11% in Q2 2026, selling an estimated $277 and leaving 8 shares worth $1.77K. The position accounts for ﹤0.01% of the portfolio, ranked #465.

Mascoma Wealth Management first reported a position in CME in Q4 2021 and has held it in 8 quarters since. The position peaked at $99.3K in Q3 2024. 1,694 funds tracked by Wall St. Rank hold CME as of Q2 2026.

  • Mascoma Wealth Management held 8 shares of CME Group worth $1.77K as of Q2 2026.
  • Mascoma Wealth Management sold 1 CME Group share in Q2 2026, an estimated $277.
  • CME Group made up ﹤0.01% of Mascoma Wealth Management's portfolio in Q2 2026, its #465 holding.
  • Mascoma Wealth Management first reported a position in CME Group in Q4 2021 and has held it in 8 quarters since.
  • Mascoma Wealth Management's CME Group position peaked at $99.3K in Q3 2024.
  • 1,694 funds tracked by Wall St. Rank held CME Group as of Q2 2026.

Based on Mascoma Wealth Management's 13F filing for Q2 2026, filed 24 Jul 2026.